Highlights
- Cipla shares gained nearly 3 percent during Tuesday’s trading session.
- The stock has outperformed the Nifty 50 across multiple time periods.
- Cipla remains below its 52-week high despite recent gains.
Cipla Limited (NSE:CIPLA), a pharmaceutical company engaged in manufacturing, developing and marketing branded formulations, generic medicines and active pharmaceutical ingredients (APIs), witnessed notable buying interest during Tuesday's trading session. The stock was trading at Rs 1,456.80, up Rs 41.00 or 2.90 percent from its previous close of Rs 1,415.70.
The share opened at Rs 1,422.80 and moved higher through the session, touching an intraday high of Rs 1,461.00. The day’s low stood at Rs 1,418.80, indicating sustained upward momentum during trading hours.
Market Position And Business Overview
Incorporated in 1935, Cipla has built a presence across branded and generic pharmaceutical products as well as APIs. The company operates in the pharmaceuticals industry and is a constituent of the Nifty 50 index.
At the current market price, Cipla commands a market capitalisation of approximately Rs 1,17,468.79 crore, while its free-float market capitalisation stands at Rs 81,572.85 crore. The stock is actively traded and remains among the larger pharmaceutical companies listed on Indian stock exchanges.
Returns Comparison Highlights Relative Strength
Cipla’s performance across various time frames reflects how the stock has fared against the benchmark Nifty 50 index. Over the last week, the stock gained 5.89 percent compared with a marginal decline of 0.03 percent in the Nifty 50. During the past month, Cipla advanced 3.92 percent, outperforming the benchmark's gain of 1.11 percent.
On a year-to-date basis, the stock has declined 3.12 percent. However, this compares favourably with the Nifty 50's decline of 8.28 percent over the same period. Over one year, Cipla fell 3.00 percent, while the benchmark index declined 3.96 percent.
Longer-term returns also remain notable. The stock has delivered returns of 46.97 percent over three years, compared with 28.48 percent for the Nifty 50. Over five years, Cipla has generated returns of 51.82 percent, broadly in line with the benchmark return of 52.88 percent.
Valuation And Trading Activity
Based on exchange data, Cipla is trading at a price-to-earnings (P/E) ratio of 29.55, while its adjusted P/E ratio stands at 27.92. During the session, around 34.54 lakh shares changed hands, resulting in traded value of approximately Rs 499.48 crore.
The stock recorded an impact cost of 0.02, reflecting trading liquidity. Deliverable volume accounted for 47.47 percent of total traded quantity during the session.
Stock Remains Below 52-Week High
Despite the recent rally, Cipla remains below its 52-week high of Rs 1,673.00 recorded on October 23, 2025. The stock's 52-week low stands at Rs 1,165.70, recorded on April 2, 2026.
At the current market price of Rs 1,456.70, the stock is trading significantly above its annual low but remains below its peak level from the past year.
Key Risks To Watch
- Regulatory observations may affect manufacturing operations.
- Pricing pressure could impact profitability across key markets.
- Currency fluctuations may influence overseas revenue performance.
- Competition in generic drugs may affect market share.
Today’s Share Performance
Cipla shares traded higher during Tuesday’s session, rising 2.90 percent to Rs 1,456.80. The stock touched an intraday high of Rs 1,461.00 and a low of Rs 1,418.80. Trading volume stood at 34.54 lakh shares, while traded value reached approximately Rs 499.48 crore. The company’s market capitalisation was Rs 1,17,468.79 crore and the stock traded at a P/E ratio of 29.55.
Source: TradingView
Summary
Cipla (NSE:CIPLA) shares gained nearly 3 percent during Tuesday's trading session, outperforming the broader market. The stock has delivered better returns than the Nifty 50 across several recent time periods, although it remains below its 52-week high. Investors may continue tracking regulatory developments, competitive dynamics, pricing trends and performance across domestic and international pharmaceutical markets.
FAQs
Q: Why did Cipla shares rise during Tuesday’s session?
A: Cipla shares gained 2.90 percent during trading, reaching an intraday high of Rs 1,461.00.
Q: How has Cipla performed compared with the Nifty 50?
A: Cipla has outperformed the benchmark across one-week, one-month and year-to-date return periods.
Q: Is Cipla trading near its 52-week high?
A: The stock remains below its 52-week high of Rs 1,673.00 recorded in October 2025.